Literature DB >> 7791423

Tetracyclines.

N C Klein1, B A Cunha.   

Abstract

Tetracyclines are relatively safe drugs with a broad antimicrobial spectrum. Doxycycline remains the preferred tetracycline agent for most indications. Doxycycline has a long half-life, which makes convenient twice-a-day dosing possible. It is well absorbed orally even in the presence of food, has excellent tissue penetration, and does not require a dose adjustment in renal insufficiency. Doxycycline is a useful agent for the treatment of atypical pneumonias, sexually transmitted diseases, traveler's diarrhea, rickettsial infections, and Lyme disease. Minocycline is the preferred drug for MRSA colonization/infection.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7791423     DOI: 10.1016/s0025-7125(16)30039-6

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN: 0025-7125            Impact factor:   5.456


  41 in total

Review 1.  Molecular detection of antimicrobial resistance.

Authors:  A C Fluit; M R Visser; F J Schmitz
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

2.  No findings of dental defects in children treated with minocycline.

Authors:  Antonio Cascio; Chiara Di Liberto; Matteo D'Angelo; Chiara Iaria; Francesco Scarlata; Lucina Titone; Giuseppina Campisi
Journal:  Antimicrob Agents Chemother       Date:  2004-07       Impact factor: 5.191

3.  Spinal glial TLR4-mediated nociception and production of prostaglandin E(2) and TNF.

Authors:  O Saito; C I Svensson; M W Buczynski; K Wegner; X-Y Hua; S Codeluppi; R H Schaloske; R A Deems; E A Dennis; T L Yaksh
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

4.  Painful nodule with induration and spreading erythema.

Authors:  Elizabeth Race; Cindy Berthelot; Jennifer Clay Cather
Journal:  Proc (Bayl Univ Med Cent)       Date:  2005-10

5.  Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia.

Authors:  J Yrjänheikki; R Keinänen; M Pellikka; T Hökfelt; J Koistinaho
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-22       Impact factor: 11.205

6.  Tetracyclines as an oral treatment option for patients with community onset skin and soft tissue infections caused by methicillin-resistant Staphylococcus aureus.

Authors:  Jörg J Ruhe; Anupama Menon
Journal:  Antimicrob Agents Chemother       Date:  2007-06-18       Impact factor: 5.191

7.  Minocycline is cytoprotective in human trabecular meshwork cells and optic nerve head astrocytes by increasing expression of XIAP, survivin, and Bcl-2.

Authors:  Marcus Kernt; Aljoscha S Neubauer; Kirsten H Eibl; Armin Wolf; Michael W Ulbig; Anselm Kampik; Cristoph Hirneiss
Journal:  Clin Ophthalmol       Date:  2010-07-21

Review 8.  Minocycline: far beyond an antibiotic.

Authors:  N Garrido-Mesa; A Zarzuelo; J Gálvez
Journal:  Br J Pharmacol       Date:  2013-05       Impact factor: 8.739

Review 9.  A review of anti-inflammatory agents for symptoms of schizophrenia.

Authors:  William R Keller; Lionel M Kum; Heidi J Wehring; Maju Mathew Koola; Robert W Buchanan; Deanna L Kelly
Journal:  J Psychopharmacol       Date:  2012-11-13       Impact factor: 4.153

10.  Dual modulation of ERK1/2 and p38 MAP kinase activities induced by minocycline reverses the neurotoxic effects of the prion protein fragment 90-231.

Authors:  Alessandro Corsaro; Stefano Thellung; Katia Chiovitti; Valentina Villa; Alessandro Simi; Federica Raggi; Domenico Paludi; Claudio Russo; Antonio Aceto; Tullio Florio
Journal:  Neurotox Res       Date:  2009-02-26       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.